Table 1.
Demographics, management, and clinical outcomes of patients presenting with ACS stratified by diabetes
| Diabetic patient (n = 598) | Non–diabetic patient (n = 1353) | p Value | |
| Demographics | |||
| Mean age (years) | 63.7 (12.3) | 63.3 (14.1) | 0.53 |
| Male | 62.2% | 65.9% | 0.11 |
| Prior myocardial infarction | 50.2% | 37.2% | <0.01 |
| Prior transient ischaemic attack/stroke | 15.5% | 10.1% | <0.01 |
| Hypertension | 81.4% | 61% | <0.01 |
| Hyperlipidaemia | 68.1% | 58.4% | <0.01 |
| Renal insufficiency | 16.2% | 5.3% | <0.01 |
| Hypertension | 81.4% | 61% | <0.01 |
| Peripheral vascular disease | 20.7% | 12.6% | <0.01 |
| Positive biomarkers | 69.2% | 71.1% | 0.38 |
| Ejection Fraction | 46.9% | 49.6% | 0.03 |
| Management | |||
| Percutaneous coronary intervention | 37.1% | 42.7% | 0.01 |
| Coronary artery bypass grafting | 8.4% | 8.1% | 0.86 |
| Intravenous glycoprotein IIb/IIIa | 21.7% | 23.2% | 0.48 |
| Thrombolytics | 5.1% | 7.9% | 0.01 |
| In-hospital events | |||
| Death | 7.3% | 4.0% | <0.01 |
| Reinfarction | 1.6% | 1.1% | 0.38 |
| Stroke | 0.84% | 1.33% | 0.34 |
| Pulmonary oedema | 10.7% | 7.3% | 0.01 |
| Major bleeding | 9.4% | 7.8% | 0.24 |
| Events by 6 months | |||
| Death | 14.2% | 8.4% | <0.01 |
| Reinfarction | 6.0% | 4.9% | 0.42 |
| Stroke | 1.9% | 1.1% | 0.20 |
| Rehospitalisation for ACS | 31.3% | 25.2% | 0.02 |